# Novo Holdings A/S 13F holdings Q2 2026: $1.7 billion

Novo Holdings A/S reported $1.7 billion in 13F securities across 25 positions for the quarter ended June 30, 2026, in a holdings report filed August 14, 2026. Its largest holding was Edgewise Therapeutics Inc at $217 million, 12.6% of the reported value. Since Q1 2026 it opened 6 new positions and exited 3.

SpecStream is the live web data engine for teams and agents. It reads the SEC's Form 13F data sets each quarter, and this page is that reading, keyed on the manager's CIK and the security's CUSIP. Ask for the managers or the holdings you track, and each new 13F filing arrives in your sheet, CRM, Slack or agent as the SEC publishes it.

- Quarter: Q2 2026, the quarter ended June 30, 2026
- Reported value: $1,722,216,880
- Positions: 25
- Filed: August 14, 2026
- Report type: 13F holdings report
- CIK: 1388325
- Form 13F file number: 028-16231
- Business address: Tuborg Havnevej 19, Hellerup, 2900 Denmark
- SEC filing: [0001388325-26-000042](https://www.sec.gov/Archives/edgar/data/1388325/000138832526000042/0001388325-26-000042-index.htm)

## Top 25 holdings by value

The largest of 25 positions by reported value at the end of the quarter ended June 30, 2026. Put and call options are marked in the class. Change is in shares or principal against the filing for the quarter ended March 31, 2026.

| Issuer | Class | Shares or principal | Value | Change since Q1 2026 |
| --- | --- | --- | --- | --- |
| [Edgewise Therapeutics Inc](https://specstream.ai/data/institutional-holders/edgewise-therapeutics-inc-28036f105) | COM | 5,350,000 | $217.4 million | No change |
| [Asml HLDG NV](https://specstream.ai/data/institutional-holders/asml-hldg-nv-n07059210) | N Y REGISTRY SHS | 94,946 | $188.9 million | No change |
| [Hemab Therapeutics Hldgs Inc](https://specstream.ai/data/institutional-holders/hemab-therapeutics-hldgs-inc-423494103) | COM SHS | 4,180,550 | $153.6 million | New |
| [Brookfield Corp](https://specstream.ai/data/institutional-holders/brookfield-corp-11271j107) | CL A LTD VT SH | 3,496,245 | $149.5 million | No change |
| [Maplight Therapeutics Inc](https://specstream.ai/data/institutional-holders/maplight-therapeutics-inc-56565p103) | COM | 3,686,622 | $132.1 million | No change |
| [Mirum Pharmaceuticals Inc](https://specstream.ai/data/institutional-holders/mirum-pharmaceuticals-inc-604749101) | COM | 1,125,000 | $131.7 million | -200,000 |
| [Avalyn Pharmaceuticals Inc](https://specstream.ai/data/institutional-holders/avalyn-pharmaceuticals-inc-05348y105) | COM SHS | 3,883,289 | $127.8 million | New |
| [Salesforce Inc](https://specstream.ai/data/institutional-holders/salesforce-inc-79466l302) | COM | 393,187 | $61.6 million | No change |
| [Arrivent Biopharma Inc](https://specstream.ai/data/institutional-holders/arrivent-biopharma-inc-04272n102) | COM | 1,500,000 | $52.1 million | -442,142 |
| [Enliven Therapeutics Inc](https://specstream.ai/data/institutional-holders/enliven-therapeutics-inc-29337e102) | COM | 1,000,000 | $50.8 million | -280,000 |
| [Crinetics Pharmaceuticals in](https://specstream.ai/data/institutional-holders/crinetics-pharmaceuticals-in-22663k107) | COM | 1,320,000 | $49.4 million | -230,000 |
| [Pharvaris N V](https://specstream.ai/data/institutional-holders/pharvaris-n-v-n69605108) | COM | 1,400,000 | $48.4 million | -350,000 |
| [Floor & Decor Hldgs Inc](https://specstream.ai/data/institutional-holders/floor-decor-hldgs-inc-339750101) | CL A | 797,000 | $47.3 million | New |
| [Vaxcyte Inc](https://specstream.ai/data/institutional-holders/vaxcyte-inc-92243g108) | COM | 800,000 | $46.5 million | -60,000 |
| [4d Molecular Therapeutics in](https://specstream.ai/data/institutional-holders/4d-molecular-therapeutics-in-35104e100) | COM | 3,249,178 | $43.2 million | -401,559 |
| [Viridian Therapeutics Inc](https://specstream.ai/data/institutional-holders/viridian-therapeutics-inc-92790c104) | COM | 2,135,000 | $39.2 million | +135,000 |
| [Celldex Therapeutics Inc New](https://specstream.ai/data/institutional-holders/celldex-therapeutics-inc-new-15117b202) | COM NEW | 1,025,000 | $38.1 million | -175,000 |
| [Alumis Inc](https://specstream.ai/data/institutional-holders/alumis-inc-022307102) | COM | 1,100,000 | $31 million | New |
| [Xenon Pharmaceuticals Inc](https://specstream.ai/data/institutional-holders/xenon-pharmaceuticals-inc-98420n105) | COM | 485,438 | $29.3 million | No change |
| [Alibaba Group HLDG LTD](https://specstream.ai/data/institutional-holders/alibaba-group-hldg-ltd-01609w102) | SPONSORED ADS | 257,327 | $24.7 million | No change |
| [Dyne Therapeutics Inc](https://specstream.ai/data/institutional-holders/dyne-therapeutics-inc-26818m108) | COM | 960,394 | $21.3 million | New |
| [Bridgebio Oncology Therapeut](https://specstream.ai/data/institutional-holders/bridgebio-oncology-therapeut-107924102) | COM NEW | 2,250,000 | $17.1 million | +64,077 |
| [Insmed Inc](https://specstream.ai/data/institutional-holders/insmed-inc-457669307) | COM PAR $.01 | 120,723 | $12.9 million | New |
| [Marqeta Inc](https://specstream.ai/data/institutional-holders/marqeta-inc-57142b104) | CLASS A COM | 441,558 | $7.2 million | No change |
| [Lanzatech Global Inc](https://specstream.ai/data/institutional-holders/lanzatech-global-inc-51655r200) | COM NEW | 158,148 | $1.1 million | No change |

## New positions in Q2 2026

6 positions not in the filing for the quarter ended March 31, 2026.

| Issuer | Class | Shares or principal | Value |
| --- | --- | --- | --- |
| [Hemab Therapeutics Hldgs Inc](https://specstream.ai/data/institutional-holders/hemab-therapeutics-hldgs-inc-423494103) | COM SHS | 4,180,550 | $153.6 million |
| [Avalyn Pharmaceuticals Inc](https://specstream.ai/data/institutional-holders/avalyn-pharmaceuticals-inc-05348y105) | COM SHS | 3,883,289 | $127.8 million |
| [Floor & Decor Hldgs Inc](https://specstream.ai/data/institutional-holders/floor-decor-hldgs-inc-339750101) | CL A | 797,000 | $47.3 million |
| [Alumis Inc](https://specstream.ai/data/institutional-holders/alumis-inc-022307102) | COM | 1,100,000 | $31 million |
| [Dyne Therapeutics Inc](https://specstream.ai/data/institutional-holders/dyne-therapeutics-inc-26818m108) | COM | 960,394 | $21.3 million |
| [Insmed Inc](https://specstream.ai/data/institutional-holders/insmed-inc-457669307) | COM PAR $.01 | 120,723 | $12.9 million |

## Positions exited in Q2 2026

3 positions in the filing for the quarter ended March 31, 2026 and not in this one, with the shares and value reported then.

| Issuer | Class | Shares or principal | Value |
| --- | --- | --- | --- |
| [Apogee Therapeutics Inc](https://specstream.ai/data/institutional-holders/apogee-therapeutics-inc-03770n101) | COM | 450,000 | $37.9 million |
| [Biomarin Pharmaceutical Inc](https://specstream.ai/data/institutional-holders/biomarin-pharmaceutical-inc-09061g101) | COM | 660,000 | $37.3 million |
| [Valneva Se](https://specstream.ai/data/institutional-holders/valneva-se-92025y103) | SPONSORED ADS | 1,057,421 | $6.6 million |

## Also on SpecStream

- [Novo Holdings A/S Form 13F filing on EDGAR](https://www.sec.gov/Archives/edgar/data/1388325/000138832526000042/0001388325-26-000042-index.htm)
- [Largest institutional managers by 13F value](https://specstream.ai/data/institutional-holdings)
- [Most widely held securities in 13F filings](https://specstream.ai/data/institutional-holders)

Source: [the SEC's Form 13F data sets](https://www.sec.gov/data-research/sec-markets-data/form-13f-data-sets). Public data published by the US Securities and Exchange Commission (US government work). Managers report these holdings themselves in Form 13F, and the SEC does not check or guarantee them. Form 13F lists long positions in US listed equities, some options and convertible notes held at the end of the quarter, and leaves out short positions, cash, most bonds and holdings below the reporting threshold. Values are market values in US dollars as the manager filed them. A manager can ask the SEC to keep some positions confidential for a time. This page uses SEC data and is not endorsed or certified by the SEC.

Free to quote with credit and a link. Copying in bulk needs a [data licence](https://specstream.ai/data/licence).

## Business lists in the United States

- [Cigar bars in the United States](https://specstream.ai/data/businesses/cigar-bars/united-states)
- [Dental hygiene clinics in the United States](https://specstream.ai/data/businesses/dental-hygiene-clinics/united-states)
- [Endodontics practices in the United States](https://specstream.ai/data/businesses/endodontics-practices/united-states)
- [Footwear wholesalers in the United States](https://specstream.ai/data/businesses/footwear-wholesalers/united-states)
- [Home insurance agencies in the United States](https://specstream.ai/data/businesses/home-insurance-agencies/united-states)
- [Irrigation contractors in the United States](https://specstream.ai/data/businesses/irrigation-contractors/united-states)
